Company intelligence / Profile preview

Trion Research

Planegg, Bavaria, Germanytrionresearch.com ↗

Ownership: Private
Employees: ~10
Development stage: Other

Overview

Trion Research is an independent research organization with a focus on developing and supporting trifunctional bispecific antibodies (Triomab®), including contributions to the development and approval of catumaxomab (Removab®). Several pipeline compounds have reached clinical development, but active internal programs appear to be in preclinical or discovery stages, with clinical validation (catumaxomab) having occurred via partnerships and out-licensing.

Therapeutic areas: OncologyImmunology
Modalities: Bispecific monoclonal antibodyMonoclonal antibodyAntibody-drug conjugateProtein
Industry: Biotech

Partnerships

Lindis BiotechTrion Pharma GmbH

Beyond the preview

Go deeper on Trion Research.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Trion Research.

Explore the full profile